Intuitive Surgical (NASDAQ:ISRG) Stock Moved Up to “Strong-Buy” by Zacks Research

Zacks Research upgraded shares of Intuitive Surgical (NASDAQ:ISRG) from a hold rating to a strong-buy rating in a research note issued to investors on Thursday morning,Zacks reports.

A number of other brokerages have also weighed in on ISRG. UBS Group reiterated a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. Raymond James Financial reissued an “outperform” rating and issued a $480.00 price target on shares of Intuitive Surgical in a research report on Wednesday. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Sunday, September 20th. BTIG Research reaffirmed a “buy” rating and issued a $454.00 price objective on shares of Intuitive Surgical in a report on Wednesday. Finally, Citigroup reduced their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research note on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $493.54.

Intuitive Surgical Trading Up 1.9%

Shares of ISRG opened at $452.29 on Thursday. The company has a market capitalization of $156.78 billion, a price-to-earnings ratio of 54.69, a PEG ratio of 3.31 and a beta of 1.46. The stock has a 50 day moving average of $395.50 and a 200 day moving average of $409.13. Intuitive Surgical has a 12 month low of $328.57 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.40 earnings per share. As a group, equities research analysts predict that Intuitive Surgical will post 8.87 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Gary Guthart sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the transaction, the director owned 1,245,679 shares in the company, valued at $498,271,600. This trade represents a 0.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the executive vice president owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. This represents a 6.99% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,370 shares of company stock worth $4,891,989 in the last three months. 0.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently modified their holdings of the company. Plato Investment Management Ltd bought a new position in Intuitive Surgical in the 2nd quarter valued at $4,315,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at $14,316,000. Hikari Power Ltd purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at $5,619,000. Nykredit A S bought a new position in shares of Intuitive Surgical in the second quarter worth $48,464,000. Finally, NewEdge Advisors LLC increased its holdings in shares of Intuitive Surgical by 19.1% in the second quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider’s stock worth $20,212,000 after purchasing an additional 8,142 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
• Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
• Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
• Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
• Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.